• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23533 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     Blue Cross Blue Shield Association (BCBS) Botulinum toxin for treatment of primary chronic headache disorders
2002     Agency for Healthcare Research and Quality (AHRQ) Postmenopausal hormone replacement therapy and cardiovascular disease
2002     HAYES, Inc. Autologous chondrocyte transplantation
2002     Medical Services Advisory Committee (MSAC) Carotid stenting
2002     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium for mesothelioma and NSCLC - horizon scanning review
2002     Blue Cross Blue Shield Association (BCBS) External counterpulsation for treatment of chronic stable angina pectoris
2002     Agency for Healthcare Research and Quality (AHRQ) Hormone replacement therapy and risk of venous thromboembolism
2002     HAYES, Inc. Transcatheter closure of septal defects
2002     Medical Services Advisory Committee (MSAC) Implantation of insertable loop recorder for the diagnosis of recurrent unexplained syncope
2002     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab for aggressive B-cell lymphoma - horizon scanning review
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions?
2002     Blue Cross Blue Shield Association (BCBS) FDG PET to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes
2002     Agency for Healthcare Research and Quality (AHRQ) Hormone replacement therapy and osteoporosis
2002     Medical Services Advisory Committee (MSAC) Neonatal hearing screening
2002     ECRI Positron imaging for differentiation of recurrent brain tumor from radionecrosis: update
2002     NIHR Horizon Scanning Centre (NIHR HSC) T-20 for HIV - horizon scanning review
2002     NIHR Health Technology Assessment programme Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C?
2002     Blue Cross Blue Shield Association (BCBS) Transesophageal endoscopic treatments for gastroesophageal reflux disease
2002     Agency for Healthcare Research and Quality (AHRQ) Hormone replacement therapy and cognition
2002     HAYES, Inc. Transilluminated powered phlebectomy for symptomatic varicose veins
2002     NIHR Health Technology Assessment programme A systematic review of the costs and effectiveness of different models of paediatric home care
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis?
2002     Blue Cross Blue Shield Association (BCBS) Chemotherapy sensitivity and resistance assays
2002     Agency for Healthcare Research and Quality (AHRQ) Hormone replacement therapy and breast cancer
2002     HAYES, Inc. Transmyocardial laser revascularization
2002     University of York The effectiveness of interventions used in the treatment/management of chronic fatigue syndrome and/or myalgic encephalomyelitis in adults and children
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) An evaluation of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions at the MUHC: is there a difference between the drugs?
2002     Blue Cross Blue Shield Association (BCBS) Percutaneous intradiscal radiofrequency thermocoagulation for chronic discogenic low back pain
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for breast cancer
2002     HAYES, Inc. Transperineal ultrasound-guided brachytherapy for early-stage prostate cancer
2002     Scottish Health Purchasing Information Centre (SHPIC) Ribavirin and interferon alfa in the treatment of chronic hepatitis C
2002     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Gamma knife and linear accelerator stereotactic radiosurgery
2002     Blue Cross Blue Shield Association (BCBS) Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for prostate cancer
2002     HAYES, Inc. Transpupillary thermotherapy for choroidal tumors and macular degeneration
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) The Pediatric Economic Database Evaluation (PEDE) project
2002     Blue Cross Blue Shield Association (BCBS) Intracoronary brachytherapy as an adjunct to percutaneous revascularization to prevent and manage restenosis
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for postmenopausal osteoporosis
2002     New Zealand Health Technology Assessment (NZHTA) Trans-gender reassignment surgery
2002     Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment perspectives on prescription writing]
2002     New Zealand Health Technology Assessment (NZHTA) Youth-specific primary healthcare - access, utilisation and health outcomes: a critical appraisal of the literature
2002     Blue Cross Blue Shield Association (BCBS) Full-field digital mammography
2002     HAYES, Inc. Botulinum toxin treatment for movement disorders
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Review of non-randomised mammographic screening programmes - Systematic review
2002     New Zealand Health Technology Assessment (NZHTA) Electronic prescribing: a critical appraisal of the literature
2002     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of immunotherapy with activated killer cells using interleukins (LAK) in metastatic melanoma: rapid response
2002     Blue Cross Blue Shield Association (BCBS) Serial endpoint testing for the diagnosis and treatment of allergic disorders
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for cervical cancer
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) The National Patient Register as a tool in clinical quality control - Primary research
2002     Andalusian Health Technology Assessment Area (AETSA) Consumers Decision Aids: synthesis of evidence and implementation in Andalusia - systematic review, expert panel
2002     Blue Cross Blue Shield Association (BCBS) Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Rheumatoid arthritis - health technology assessment of diagnosis and treatment]
2002     Norwegian Knowledge Centre for the Health Services (NOKC) Implantable defibrillator
2002     Andalusian Health Technology Assessment Area (AETSA) [Genetic testing services for hereditary diseases in Spain: results from a survey - primary research]
2002     Blue Cross Blue Shield Association (BCBS) High-dose chemotherapy plus allogeneic stem cells to treat chronic lymphocytic leukemia or small lymphocytic lymphoma
2002     Agency for Healthcare Research and Quality (AHRQ) Aspirin for the primary prevention of cardiovascular events
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Quality of mammographic screening programmes]
2002     Norwegian Knowledge Centre for the Health Services (NOKC) Treating prostate cancer with brachytherapy
2002     Blue Cross Blue Shield Association (BCBS) Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas
2002     HAYES, Inc. Breast ductal lavage for cytological examination in women at high risk for breast cancer
2002     HAYES, Inc. Umbilical cord blood stem cell transplantation
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Chlamydia screening with home testing - a health technology assessment]
2002     Norwegian Knowledge Centre for the Health Services (NOKC) Children born from intracytoplasmic sperm injection
2002     Blue Cross Blue Shield Association (BCBS) Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus
2002     HAYES, Inc. Unicompartmental knee replacement surgery
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Embolization of uterine fibroids - Early Warning on New Health Technology]
2002     Blue Cross Blue Shield Association (BCBS) Use of epithelial cell cytology in breast cancer risk assessment and high-risk patient management
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Iressa for non-small cell lung cancer - Early Warningon New Health Technology 2002 1(2)
2002     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Doppler ultrasonography in peripheral arterial occlusive disease of the lower limbs
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for depression
2002     HAYES, Inc. Cardiac resynchronization therapy for heart failure
2002     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Fetal heart rate monitoring protocols during normal labour: indications and benefits
2002     Agency for Healthcare Research and Quality (AHRQ) Counseling to promote a healthy diet
2002     TNO Patient satisfaction in integrated care
2002     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of Tension-free vaginal tapes in patients with urinary incontinence during efforts
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tiotropium bromide
2002     ECRI Endovenous radio-frequency obliteration (VNUS Closure system) for treatment of varicose veins
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ertapenem
2002     Agency for Healthcare Research and Quality (AHRQ) Clinical counseling and physical activity
2002     HAYES, Inc. Chemoembolization for primary liver cancer
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Etoricoxib
2002     HAYES, Inc. Vision therapy for visual dysfunctions and dyslexia and other reading disabilities
2002     ECRI Extracorporeal shockwave therapy for epicondylitis
2002     HAYES, Inc. Water-induced thermotherapy (WIT) for benign prostatic hyperplasia
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Aripiprazole
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Darbepoetin alpha
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Glimepiride
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Counselling services in mental health/primary care
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treprostinil
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Studies and scales used in technologies within the orthoprosthetic benefits. IPE-02/33 (Public report)
2002     HAYES, Inc. Conformal radiation therapy for prostate cancer
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tegaserod hydrogen maleate
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Post-polio syndrome: revision of the literature, situation in Spain and possible performance lines (public report). CISNS-02/07
2002     NIHR Health Technology Assessment programme A study of the methods used to select review criteria for clinical audit
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Valdecoxib
2002     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Cataract surgery: definition of indication and utilisation criteria in Catalonia
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy